Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation백신 접종 대 SARS-CoV-2 감염: 높은 결합력 IgG 반응의 확립 대 불완전한 결합력 성숙Article Published on 2021-12-012022-09-12 Journal: Journal of medical virology [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome avidity binding Complete coronavirus coronavirus disease COVID-19 defined domain epitope Epitopes facilitate IgG IgG response Immunity Immunoglobulin Incomplete individual induce Infection infection with SARS-CoV-2 initial maturation Messenger RNA mRNA naïve individual naïve individuals patients Prevent Protective protective immunity RBD Receptor-binding domain recomLine SARS-CoV-2 IgG SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected individuals vaccination [DOI] 10.1002/jmv.27270 PMC 바로가기 [Article Type] Article
Resilience and mental health in individuals with spinal cord injury during the COVID-19 pandemicObservational Study Published on 2021-12-012022-10-05 Journal: Spinal cord [Category] SARS, 임상, [키워드] age ameliorated anxiety symptoms Care collected COVID-19 pandemic Decreased Depression Depressive symptoms Effect ENhance greater IMPROVE Incomplete individual Injury mental health offered pandemic PCA predicted Quality of life Resilience resource social isolation Spinal cord injury [DOI] 10.1038/s41393-021-00708-3 PMC 바로가기 [Article Type] Observational Study
The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture중증 급성 호흡기 증후군 코로나바이러스 2 감염의 자연사: 합성이지만 불완전한 그림Editorial Published on 2021-11-022022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 진단, [키워드] Abstract anti-SARS-CoV-2 antibodies Composite coronavirus 2 COVID-19 COVID-19 natural history history Incomplete natural respiratory SARS-CoV-2 SARS-CoV-2 infectivity [DOI] 10.1093/cid/ciaa1413 PMC 바로가기 [Article Type] Editorial
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection불완전한 항바이러스 치료는 SARS-CoV-2 감염 동안 더 긴 기간의 바이러스 배출을 유발할 수 있습니다Research Article Published on 2021-08-032022-09-10 Journal: Life Science Alliance [Category] MERS, SARS, 치료제, [키워드] antiviral drug antiviral drugs Antiviral treatment balance blocked with characterized de novo determined by driven by Efficacy Incomplete induce infected cells infected individual infected individuals Infection initiated Kinetics mathematical mathematical model Mathematical models non-human primate non-human primates predict quantified removal SARS-COV-2 infection treated Treatment uninfected cell uninfected cells Viral viral shedding virus virus production virus replication [DOI] 10.26508/lsa.202101049 PMC 바로가기 [Article Type] Research Article
A Nationwide Cross-Sectional Online Survey on the Treatment of COVID-19-ARDS: High Variance in Standard of Care in German ICUsArticle Published on 2021-07-292022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] adherence Admission benefit Care clinical variability concerning conducted COVID-19 COVID-19 pandemic COVID-19 patients cross-sectional disease ECMO Emergency Epidemiology extracorporeal membrane oxygenation Germany highlighting hospital ICU Incomplete Intervention intubation lack Medicine pathophysiology patients PEEP physician positive Quantitative recommendations reported Research Respiratory failure significant difference Standard survey the disease tracheotomy Treatment treatment strategy variance variance of care Ventilation [DOI] 10.3390/jcm10153363 PMC 바로가기 [Article Type] Article
ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 ReplicationCell and Developmental Biology Published on 2021-07-272022-10-31 Journal: Frontiers in Cell and Developmental Biology [Category] COVID-19, [키워드] Amino acid autophagic autophagy autophagy machinery Beclin 1 cellular cellular response coronavirus disease COVID-19 declined demonstrated Efficiency elevated Evidence expression facilitate form genetic knockout had no Host identity Incomplete induce inhibit interact maturation ORF3a pandemic pathway Protein raise reduce respiratory responsible SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 replication the SARS-CoV-2 Treatment Trigger UVRAG Viral protein [DOI] 10.3389/fcell.2021.716208 PMC 바로가기 [Article Type] Cell and Developmental Biology
Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report유아의 COVID-19 감염을 나타내는 불완전 가와사키병: 증례 보고Case Reports Published on 2021-07-022022-09-12 Journal: Journal of tropical pediatrics [Category] SARS, 진단, [키워드] Aspirin C-reactive protein chain children Cluster COVID-19 COVID-19 infection descending described diagnosed discharged echocardiography elevated Fever Incomplete incomplete Kawasaki disease Infant Infection inflammatory condition Intravenous immunoglobulin irritability Kawasaki disease male outcome positive presentation presenting reaction report skin rash treated with COVID-19 Z score [DOI] 10.1093/tropej/fmaa047 PMC 바로가기 [Article Type] Case Reports
Factors Influencing SARS-CoV-2 Vaccine Acceptance and Hesitancy in a Population-Based Sample in ItalyArticle Published on 2021-06-102022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% CI acceptance collected COVID-19 COVID-19 vaccine COVID-19 vaccines effective eligible evaluate Factor General population help Hesitancy Immunity Incomplete Intention Italy Male sex MOST Older pandemic participant predictor PROTECT questionnaire Safe Sample SARS-CoV-2 severity survey the vaccine vaccinated against COVID-19 Vaccine acceptance Vaccine hesitancy were excluded [DOI] 10.3390/vaccines9060633 PMC 바로가기 [Article Type] Article
Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome급성기 비입원 COVID-19 환자의 불완전한 전신 회복 및 대사성 표현 전환: Post-Acute COVID-19 증후군 평가에 대한 시사점Article Published on 2021-06-042022-09-11 Journal: Journal of Proteome Research [Category] SARS, 치료기술, [키워드] acute COVID-19 acute respiratory syndrome adaptive amino acids Analysis analyzed Anosmia approach assessment Asymptomatic biochemical Biomarker Biomarkers blood sample Blood samples Chronic fatigue Control controls Correlation analysis cough COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients discriminant analysis Dyspnea elevated exhibiting Follow-up functional Functional assessment Glutamate Glutamine Glycoproteins greater healthy control healthy controls Hospitalized immune immune function in some Incomplete Infection joint joint pain Kynurenine Lipoproteins liver long-COVID long-COVID syndrome mass spectrometry metabolic Metabolic data metabolites Multiorgan multiorgan disease multiple parameter multiple parameters myalgia NMR nuclear magnetic resonance Other Pain parameter pathophysiology pathway Patient patients PCA phenoconversion phenoreversion phenotype plasma plasma samples Post-acute COVID-19 syndrome Principal component principal component analysis reduced reduction in remained resonance respiratory-related symptom respiratory-related symptoms rhinorrhea SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positive patient Severe acute respiratory syndrome Significant significantly significantly lower Spectrum Symptom symptomatic symptomatic patient Symptomatic patients syndrome systemic systemic inflammatory Taurine the healthy the patient tissue repair Tryptophan was normalized [DOI] 10.1021/acs.jproteome.1c00224 PMC 바로가기 [Article Type] Article
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan일본의 무증상 코로나19 환자에서 중화항체를 포함한 불완전한 체액 반응Article Published on 2021-03-012022-09-11 Journal: Virology [Category] SARS, 진단, 치료법, [키워드] acquisition antibodies antibody Asymptomatic asymptomatic to mild clinical Clinical features controls correlated COVID-19 COVID-19 patient CRP D-dimer disease disease severity domain enrolled examined Extracellular humoral Humoral immunity immune response Incomplete Japan lymphopenia Mild mild COVID-19 patients mild patient mild patients MOST N protein neutralization titer neutralization titers neutralizing antibody Neutralizing assay Neutralizing titer neutralizing titers pandemic of COVID-19 patients with asymptomatic PCR test Pneumonia procalcitonin Receptor-binding domain reported S1 domain SARS-CoV-2 serological test serum antibodies serum antibody spike spike-ACE2 Symptom Virus neutralization [DOI] 10.1016/j.virol.2020.12.020 PMC 바로가기 [Article Type] Article